ROMANO, Mario
 Distribuzione geografica
Continente #
NA - Nord America 3.647
EU - Europa 3.241
AS - Asia 2.306
SA - Sud America 187
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
Totale 9.437
Nazione #
US - Stati Uniti d'America 3.571
SG - Singapore 878
IT - Italia 683
CN - Cina 671
IE - Irlanda 471
UA - Ucraina 453
SE - Svezia 380
GB - Regno Unito 365
TR - Turchia 353
FR - Francia 300
DE - Germania 230
IN - India 229
BR - Brasile 149
FI - Finlandia 125
RU - Federazione Russa 85
CA - Canada 51
HK - Hong Kong 44
VN - Vietnam 42
AT - Austria 40
NL - Olanda 21
PL - Polonia 21
PE - Perù 17
JP - Giappone 16
ES - Italia 15
BE - Belgio 14
CZ - Repubblica Ceca 14
EG - Egitto 12
IR - Iran 12
ZA - Sudafrica 12
EU - Europa 11
BD - Bangladesh 10
MX - Messico 10
AU - Australia 9
BZ - Belize 9
AR - Argentina 8
IL - Israele 8
KR - Corea 7
PK - Pakistan 6
CL - Cile 5
TW - Taiwan 5
MA - Marocco 4
RO - Romania 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
IQ - Iraq 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
UZ - Uzbekistan 3
VE - Venezuela 3
CO - Colombia 2
EE - Estonia 2
KE - Kenya 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 9.437
Città #
Chandler 666
Singapore 621
Jacksonville 517
Dublin 465
Southend 268
Princeton 207
Izmir 201
Beijing 148
Ashburn 133
Nanjing 132
New York 123
Santa Clara 114
Dearborn 112
The Dalles 110
Boardman 107
Chieti 101
Altamura 90
Wilmington 88
Cambridge 80
Ann Arbor 73
Tongling 66
Nanchang 63
Pescara 53
Los Angeles 47
Rome 44
Helsinki 35
Montesilvano 34
Vienna 34
Hong Kong 31
Munich 30
San Mateo 29
Hebei 24
Washington 24
Woodbridge 24
Tianjin 23
Dong Ket 22
Shenyang 22
Düsseldorf 21
Jiaxing 21
Kunming 21
Falls Church 20
Nuremberg 20
Houston 19
Montreal 19
Toronto 19
Augusta 18
Hefei 18
Tokyo 16
Brussels 14
Cornaredo 14
Frankfurt am Main 14
Grevenbroich 14
San Francisco 14
Milan 13
Brooklyn 12
Central 12
Changsha 12
Cairo 10
Chicago 10
Ica 10
Orange 10
San Buono 10
Seattle 10
Turku 10
Warsaw 10
Boston 9
Brno 9
Johannesburg 9
London 9
Ascoli Piceno 8
Hangzhou 8
Jinan 8
Lanzhou 7
Leawood 7
Lima 7
Meylan 7
Norwalk 7
Piotrkow Trybunalski 7
São Paulo 7
Ancona 6
Changchun 6
Chengdu 6
Ningbo 6
Stockholm 6
Tappahannock 6
Fuzhou 5
Hanoi 5
Lanciano 5
Madrid 5
Melbourne 5
Redwood City 5
Saint-prix 5
Shanghai 5
Vasto 5
Amsterdam 4
Ardabil 4
Auburn Hills 4
Bari 4
Columbus 4
Denver 4
Totale 5.586
Nome #
Sistema di rilascio della lipossina A4 mediante membrana polimerica porosa ottenuta con elettrofilatura 283
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 166
Molecular and phenotypic characterization of human amniotic fluid-derived cells: A morphological and proteomic approach 154
Wnt Signaling Behaves as a "Master Regulator" in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem Cells 150
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 148
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 147
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 142
Establishment and long-term culture of human cystic fibrosis endothelial cells 142
Impiego di cellule staminali da legamento parodontale per lo screening farmacologico in fibrosi cistica. 141
Mechanisms of endothelial cell dysfunction in cystic fibrosis 140
Pentraxin 3 and platelet activation in obese patients after gastric banding 137
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 134
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 125
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 112
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 112
Lipoxins, resolvins, and the resolution of inflammation 110
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 109
Immobilization and delivery of biologically active Lipoxin A4 using electrospinning technology 109
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 108
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 106
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 106
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 105
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 105
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 104
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 103
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 103
Increased soluble CD40L levels in cystic fibrosis 102
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 102
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 102
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 100
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 100
Lipoxin receptors 99
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 99
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 99
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 98
Epigenetic regulation of the formyl peptide receptor 2 gene 97
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 96
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 95
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen 95
Activation of human monocytes and the acute monocytic cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 and lipoxin B4: evidence for differential Ca2+ mobilization 93
Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples 92
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 92
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 92
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 92
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 91
Transcellular regulation of eicosanoids biosyntesis 90
Diabetes mellitus during pregnancy interferes with the biological characteristics of wharton's jelly mesenchymal stem cells 90
Leptin increase is associated with markers of the hemostatic system in obese healthy women 89
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 89
Homocysteine modulates the CD40/CD40L system 88
Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders 87
Increased levels of soluble P-selectin in hypercholesterolemic patients 87
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 85
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 84
3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics 83
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 83
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 83
Induction of functional Lipoxin A4 receptors in HL-60 cells 82
Myelofibrosis: A role for Platelet Derived Growth Factor (PDGF) ? 81
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 81
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R 80
Reduced platelet mitogenic activity in myeloproliferative disorders 80
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 80
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 80
Methionine aminopeptidase-2 regulates human mesothelioma cell survival - Role of bcl-2 expression and telomerase activity 80
Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C 79
Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer 79
Lipoxin biosynthesis and actions: role of the human platelet LX-Synthase 79
Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study 79
Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells 78
Lipoxin and aspirin-triggered lipoxins 78
Hepatocytes are a rich source of novel aspirin-trigged 15-epi-lipoxin A(4) 77
Cyclooxygenase-2-derived lipoxin A(4) increases gastric resistance to aspirin-induced damage 77
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin 77
5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 77
Cyclooxygenase-2 and 5-Lipoxygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy 76
Lipoxin synthase activity of human platelet 12-Lipoxygenase 75
Inflammation resolution: does the bone marrow have a say? 74
Peptido-leukotrienes stimulate von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells 73
Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: Another paradox of longevity? 73
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 73
Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins 73
Human alveolar macrophages generate 15-HETE and can produce lipoxins 71
Lipoxin generation by human magakaryocyte-induced 12-lipoxygenase 70
Ligand bias and its association with pro-resolving actions of melanocortin drugs 70
Lipoxin generation by permeabilized human platelets 69
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 69
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells 69
Proteomics investigation of human platelets by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study 68
Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils 68
Fluticasone propionate reduces serum interleukin 8 in asthmatic patients 67
Endothelial perturbation in cystic fibrosis. 67
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 66
Endotoxic Lipid A induces intracellular Ca2+ increase in human platelets 64
Lipoxin analogs and lipoxin formation in vivo 64
NEW GENETIC AND PHARMACOLOGICAL TREATMENTS FOR CYSTIC FIBROSIS 62
Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa 61
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 61
The Resolution Approach to Cystic Fibrosis Inflammation 60
Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip: Cystic fibrosis airway chip 59
Totale 9.401
Categoria #
all - tutte 41.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.983


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021705 0 10 104 27 64 126 54 18 124 104 28 46
2021/2022600 9 14 4 145 26 16 10 39 38 39 81 179
2022/20231.804 130 246 111 213 183 327 86 144 234 26 50 54
2023/20241.011 78 46 49 30 57 294 185 51 19 46 22 134
2024/20252.229 130 381 319 83 81 97 78 118 246 92 267 337
2025/2026346 321 25 0 0 0 0 0 0 0 0 0 0
Totale 9.844